Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anneli Pitkänen, Maritta Välimäki, Jean Endicott, Jouko Katajisto, Tiina Luukkaala, Marita Koivunen, Lauri Kuosmanen & Heli Hätönen. (2012) Assessing quality of life in patients with schizophrenia in an acute psychiatric setting: Reliability, validity and feasibility of the EQ-5D and the Q-LES-Q. Nordic Journal of Psychiatry 66:1, pages 19-25.
Read now
Read now
Raimo K R Salokangas, Sinikka Luutonen, Mervi Nieminen, Hasse Karlsson, Raimo K R Salokangas, Sinikka Luutonen, Mervi Nieminen & Hasse Karlsson. (2006) Psychotism and its dimensions in primary care. Associations with patient's background and manic and depressive symptoms. Results of the RADEP study. Nordic Journal of Psychiatry 60:6, pages 492-500.
Read now
Read now
Articles from other publishers (30)
Zhen Mao, Lu Tian, Yue Sun, Fang Dong, Chuanyue Wang & Qijing Bo. (2023) Quality of life and its predictors in first-episode schizophrenia and individuals at clinical high-risk for psychosis. BMC Psychiatry 23:1.
Crossref
Crossref
Iman Amro, Suhaila Ghuloum, Samer Hammoudeh, Yahya Hani, Arij Yehya & Hassen Al-Amin. (2022) Thematic analysis of the raters’ experiences administering scales to assess depression and suicide in Arab schizophrenia patients. BMC Psychiatry 22:1.
Crossref
Crossref
Wai Tong Chien, David R. Thompson, Sau Fong Leung & Daniel Bressington. (2020) Quality of life, symptom severity and level of functioning in people with severe mental illness ready for hospital discharge. Journal of Psychiatric and Mental Health Nursing 29:1, pages 14-24.
Crossref
Crossref
Kristiina Puolakka & Anneli Pitkänen. (2019) Effectiveness of psychosocial interventions on quality of life of patients with schizophrenia and related disorders: A systematic review. Archives of Psychiatric Nursing 33:5, pages 73-82.
Crossref
Crossref
Inge Faarup, Jørgen T. Lauridsen, Karin Lütgen, Anni Nørregaard, Frantz Rom Poulsen & Birte Østergaard. (2019) Do family health conversations impact patients with glioblastoma multiforme and their family members?. Journal of Clinical Nursing 28:9-10, pages 1695-1707.
Crossref
Crossref
N. Maslenikov, E. Tsukarzi & S. Mosolov. (2019) Repetitive transcranial magnetic stimulation (rTMS) versus antidepressants as an add-on treatment for depression in schizophrenia. European Neuropsychopharmacology 29, pages S230-S231.
Crossref
Crossref
Ole Schjerning, Per Damkier, Signe Engelhardt Lykkegaard, Klaus Damgaard Jakobsen & Jimmi Nielsen. (2018) Pregabalin for anxiety in patients with schizophrenia — A randomized, double-blind placebo-controlled study. Schizophrenia Research 195, pages 260-266.
Crossref
Crossref
Sarah E. Herniman, Kelly A. Allott, Eóin Killackey, Robert Hester & Sue M. Cotton. (2017) The psychometric validity of the Center for Epidemiological Studies – Depression Scale (CES-D) in first episode schizophrenia spectrum. Psychiatry Research 252, pages 16-22.
Crossref
Crossref
Clara R Medici, Claus H Vestergaard, Peter Hjorth, Mette V Hansen, Jan WD Shanmuganathan, Anne G Viuff & Povl Munk-Jørgensen. (2015) Quality of life and clinical characteristics in a nonselected sample of patients with schizophrenia. International Journal of Social Psychiatry 62:1, pages 12-20.
Crossref
Crossref
Jakob Bue Bjorner & Per Bech. 2016. Beyond Assessment of Quality of Life in Schizophrenia. Beyond Assessment of Quality of Life in Schizophrenia
103
120
.
Tore Bonsaksen. (2013) Changes during hospital treatment in patients with SMI. British Journal of Mental Health Nursing 2:3, pages 162-170.
Crossref
Crossref
Anneli Pitkänen & Kristiina Puolakka. (2013) Effectiveness of psychological and psychosocial interventions on quality of life of patients with schizophrenia and related disorders: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 11:6, pages 157-168.
Crossref
Crossref
Helen Walker, Lindsay Tulloch & Colin Martin. (2012) Are they worth it? A systematic review of QOL instruments for use with mentally disordered offenders who have a diagnosis of psychosis. The British Journal of Forensic Practice 14:4, pages 252-268.
Crossref
Crossref
Ulrich Reininghaus & Stefan Priebe. (2018) Measuring patient-reported outcomes in psychosis: conceptual and
methodological review. British Journal of Psychiatry 201:4, pages 262-267.
Crossref
Crossref
Irene M. Lako, R. Bruggeman, H. Knegtering, D. Wiersma, R.A. Schoevers, C.J. Slooff & K. Taxis. (2012) A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. Journal of Affective Disorders 140:1, pages 38-47.
Crossref
Crossref
Tore Bonsaksen. (2012) Exploring gender differences in quality of life. Mental Health Review Journal 17:1, pages 39-49.
Crossref
Crossref
Carol Harvey, Graeme Hawthorne, Amanda Favilla, Carolyn Graham & Helen Herrman. (2012)
Antipsychotic medicines in
A
ustralian community practice: Effectiveness, adverse effects and quality of life for people with schizophrenia
. Asia-Pacific Psychiatry 4:1, pages 48-58.
Crossref
Crossref
Amitava Dan, Suresh Kumar, Ajit Avasthi & Sandeep Grover. (2011) A comparative study on quality of life of patients of schizophrenia with and without depression. Psychiatry Research 189:2, pages 185-189.
Crossref
Crossref
P. Bech, P. Tanghøj, K. Andreasson & K. F. Overø. (2011) Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle. Acta Psychiatrica Scandinavica 123:2, pages 154-161.
Crossref
Crossref
Samanta E. Fröhlich, Anamaria V. Zaccolo, Sabrina L. C. da Silva & Sotero S. Mengue. (2010) Association between drug prescribing and quality of life in primary care. Pharmacy World & Science 32:6, pages 744-751.
Crossref
Crossref
Per Bech, Per Tanghøj, Kate T. Andreasson & Kerstin Overø. (2010) SERTINDOLE AND HALOPERIDOL REVISITED; THE PSYCHOMETRIC TRIANGLE. Schizophrenia Research 117:2-3, pages 259.
Crossref
Crossref
Robert R. Conley. (2009) The Burden of Depressive Symptoms in People with Schizophrenia. Psychiatric Clinics of North America 32:4, pages 853-861.
Crossref
Crossref
Rozmin Halari, Preethi Premkumar, Lorna Farquharson, Dominic Fannon, Elizabeth Kuipers & Veena Kumari. (2009) Rumination and Negative Symptoms in Schizophrenia. Journal of Nervous & Mental Disease 197:9, pages 703-706.
Crossref
Crossref
Kyoung‐Uk Lee, Yang‐Whan Jeon, Hae‐Kook Lee & Tae‐Youn Jun. (2009) Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. Human Psychopharmacology: Clinical and Experimental 24:6, pages 447-452.
Crossref
Crossref
A. PITKÄNEN, H. HÄTÖNEN, L. KUOSMANEN & M. VÄLIMÄKI. (2009) Individual quality of life of people with severe mental disorders. Journal of Psychiatric and Mental Health Nursing 16:1, pages 3-9.
Crossref
Crossref
Georg Juckel & Pier Luigi Morosini. (2008) The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Current Opinion in Psychiatry 21:6, pages 630-639.
Crossref
Crossref
S. Ruhrmann, J. Paruch, A. Bechdolf, R. Pukrop, M. Wagner, J. Berning, F. Schultze-Lutter, B. Janssen, W. Gaebel, H.-J. Möller, W. Maier & J. Klosterkötter. (2008) Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatrica Scandinavica 117:5, pages 357-368.
Crossref
Crossref
Massimo C. Mauri, Donatella Moliterno, Matteo Rossattini & Alessandro Colasanti. (2008) Depression in schizophrenia: Comparison of first- and second-generation antipsychotic drugs. Schizophrenia Research 99:1-3, pages 7-12.
Crossref
Crossref
Petar Opalic & Sanja Nikolic. (2008) Evaluation of schizophrenic patients quality of life. Vojnosanitetski pregled Military Medical and Pharmaceutical Journal of Serbia 65:5, pages 383-391.
Crossref
Crossref
RAJIV TANDON, STEVEN D. TARGUM, HENRY A. NASRALLAH & RUTH ROSS. (2006) Strategies for Maximizing Clinical Effectiveness in the Treatment of Schizophrenia. Journal of Psychiatric Practice 12:6, pages 348-363.
Crossref
Crossref